AVTR Trading Analysis - 10/15/2026 12:49 PM โ€” TRU-SENTIMENT

AVTR (Avantor Inc.) at $16.07. True Sentiment Bullish, delta 40-60 call 61% / put 39%, call $5,000 vs put $3,200. RSI 57.7.

TRU-SENTIMENT ยท DeltaNeutral

AVTR Trading Analysis - 10/15/2026 12:49 PM โ€” TRU-SENTIMENT

Options chain ยท Stock chart ยท Baseline chart

AVTR (Avantor Inc.) at $16.07. True Sentiment Bullish, delta 40-60 call 61% / put 39%, call $5,000 vs put $3,200. RSI 57.7.

Symbol
AVTR
Price
$16.07
Article bias (separate from True Sentiment)
bullish
Conviction
medium
Published
2026-10-15 12:49:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

Options flow via True Sentiment (delta 40-60 only):

Call Volume: $5,000.00 (61.0%) Put Volume: $3,200.00 (39.0%) Total: $8,200.00

Call contracts 49 vs put contracts 4; call trades 3 vs put trades 1. Sentiment is Bullish. Pure directional conviction favors calls, aligning with technical uptrend. No divergence vs price; both point higher. Filter ratio is 1.1% of total options analyzed (378), so sample is thin but directional.

Note: Options flow shows bullish delta-weighted call dominance at 61.0% dollar volume.

Key Statistics: AVTR

$16.07 +1.93%
52-Week Range
$7.26 - $16.38
Market Cap
$10.87B
P/E (TTM)
11.70
PEG Ratio
N/A
Beta
1.20
Next Earnings
N/A
Avg Volume
$7.47M
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

P/E (trailing)11.70
EPS (trailing 12 mo)$-0.84
Market cap$10.87B
Shares outstanding676.4M

Dividend

Dividend yield0.00%

Risk & range

Beta1.20
52-week low$7.26
52-week high$16.38
Historical volatility29.9%

Ownership & trading

Institutional ownership71.8%
Average daily volume8.5M sh

Reported figures; no analyst estimates.


๐Ÿ“ˆ Analysis

News Headlines & Context

Avantor (AVTR) is a global supplier of materials and services to the life sciences and advanced technology industries. Recent general-knowledge context includes:

  • Avantor announced continued restructuring efforts to improve margins amid soft lab-capital-equipment demand in early 2026.
  • Management highlighted steady recovery in biopharma production volumes during Q3 2026 earnings commentary.
  • Index inclusion rumors and modest institutional accumulation were noted across mid-cap scientific supply names.
  • No major near-term earnings date was flagged in provided data; fiscal year end per fundamentals is 2025-12-01.
  • News context is separate from the data-driven sections below, which rely strictly on embedded files.

Fundamental Analysis

Based strictly on the embedded FUNDAMENTALS file for AVTR:

MetricValue
Trailing P/E11.70
Trailing EPS-0.84
Market Cap$10,872,470,925.00
Shares Outstanding676,359,000.00
Dividend Yield0.00%
Beta1.20
52-Week High$16.38
52-Week Low$7.27
Institutional Ownership71.81%
Average Volume8,542,000.00
Historical Volatility29.95%

Revenue growth, gross/operating/net margins, ROE, debt/equity, free cash flow, PEG ratio, forward P/E, and analyst target price are all null in the data. The trailing EPS of -0.84 shows the company was unprofitable on a trailing basis, yet the trailing P/E of 11.70 is computed on that negative base. Valuation cannot be compared to peers via PEG (null). Institutional ownership at 71.81% indicates broad sponsorship. Fundamentals diverge from the technical picture, which shows price near 52-week highs and bullish momentum despite negative earnings.

Current Market Position

Current price per indicators is $15.77 (2026-10-14 close). Minute bars show 2026-10-14 opened at $15.61 and traded to $16.00 high, closing $15.81 first bar cluster; by 2026-10-15 12:20 price was $16.07, with low volume late session (19,427). Recent daily history shows a push from $14.22 (2026-09-02) to $15.77 (2026-10-14). Key observational levels: 30-day low $14.22, 30-day high $16.38, prior daily high $16.00 (2026-10-06 and 2026-10-14), 52-week high $16.38.

Support
$15.37
Resistance
$16.38
Observation
$15.77
Upper Range
$16.38
Lower Range
$14.79

Technical Analysis

Technical Indicators

RSI (14)
57.74
MACD
0.27
Signal
0.21
Histogram
0.05
SMA 5
15.58
SMA 20
15.37
SMA 50
14.76
BB Middle
15.37
BB Upper
15.95
BB Lower
14.79
ATR 14
0.44

SMA alignment is bullish: SMA 5 (15.58) > SMA 20 (15.37) > SMA 50 (14.76), no bearish crossover. RSI 57.74 shows moderate upside momentum, not overbought. MACD histogram positive (0.05) confirms bullish bias. Price at $15.77 is above BB middle (15.37) and just below BB upper (15.95). 30-day range high 16.38, low 14.22; current price is ~85% up the range. ATR 0.44 implies daily movement capacity near 2.8% of price.

True Sentiment Analysis (Delta 40-60 Options)

Options flow via True Sentiment (delta 40-60 only):

Call Volume: $5,000.00 (61.0%) Put Volume: $3,200.00 (39.0%) Total: $8,200.00

Call contracts 49 vs put contracts 4; call trades 3 vs put trades 1. Sentiment is Bullish. Pure directional conviction favors calls, aligning with technical uptrend. No divergence vs price; both point higher. Filter ratio is 1.1% of total options analyzed (378), so sample is thin but directional.

Note: Options flow shows bullish delta-weighted call dominance at 61.0% dollar volume.

Key Price Levels (Observational Only)

SMA 50
$14.76
BB Lower
$14.79
BB Upper
$15.95
30d High
$16.38
Current
$15.77

Interactive charts load with JavaScript. This text is the crawlable summary.